4//SEC Filing
Mottiwala Aziz 4
Accession 0001209191-23-036395
CIK 0001819790other
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 5:25 PM ET
Size
4.8 KB
Accession
0001209191-23-036395
Insider Transaction Report
Form 4
Mottiwala Aziz
Chief Commercial Officer
Transactions
- Sale
Common Stock
2023-06-08$20.00/sh−100$2,000→ 48,086 total
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 26, 2022.
Documents
Issuer
Tarsus Pharmaceuticals, Inc.
CIK 0001819790
Entity typeother
Related Parties
1- filerCIK 0001788542
Filing Metadata
- Form type
- 4
- Filed
- Jun 11, 8:00 PM ET
- Accepted
- Jun 12, 5:25 PM ET
- Size
- 4.8 KB